The company vide this IPO seeks to utilize the net proceeds to set up a new manufacturing unit at Sawarda, Jaipur, Rajasthan for its Wholly-Owned Subsidiary Shri Ahimsa Healthcare Private Limited (SAHPL),  and general corporate purposes.

The table below (in lakhs) stipulates the restated Financial Information of the company over the last 3 fiscal years and up-till September 30, 2024.

The Nutraceutical industry in India is a leading market with the country on the path to becoming a global leader at USD 4-5 billion. There have been growing concerns about health issues in India, especially concerning obesity.

Health awareness for weight loss has grown and people are engaging in more physical exercises and adhering to strict diet plans along with utilizing various diet supplements for weight loss. Caffeine has a huge global demand for its health benefits like antioxidants, energy and brain stimulation, physical endurance, weight management, blood sugar control, etc.

Similarly, the supplement Caffeine Anhydrous, and Green coffee bean extract are supplements that offer more potent doses and work as a very effective supplement for weight loss. The consumption of this supplement has rapidly increased and is being utilized in various beverage segments and the dietary supplementary sector. The market of Caffeine Anhydrous is projected to increase at a CAGR of 6.88% and grow from USD 622.4 million in 2023 to USD 881.5 million by 2030, and the Green coffee bean extract is also projected to increase at a CAGR of 4.0 % and grow from US$ 281.2  million in 2023 to USD 417 million by 2030.

India is also known as the "pharmacy of the world" due to the low cost and high quality of its medicines. The Nutraceutical Industry globally was valued at USD 317.22 billion in 2023 and is projected to grow at a CAGR of 9.6% from 2024 to 2030, in India the same is expected to grow approximately by USD 18 billion by 2025.

The Nutraceutical market is growing domestically and internationally due to the rising health concerns being addressed seriously. There has been a growing consciousness of being healthy and fit and for this purpose, health care supplements are in huge demand.

This market has strong growth potential due to the rising demand for many health supplements. The company has also shown strong fundamentals and healthy returns over the years. 

However, the company is also subject to certain risks and competition which the investors should carefully analyze before investing.

The company with the help of this Initial Public Offering (IPO) aims to open a new manufacturing unit for its Wholly-Owned Subsidiary Shri Ahimsa Healthcare Private Limited (SAHPL) at Sawarda, Jaipur, Rajasthan, and for general corporate purposes.

It has shown healthy profits and strong fundamentals in the business it operates in but, the company is also subject to certain risks which investors should outline before investing.